The emerging approach of the medication represents a major development in the management of type 2 diabetes. Distinct from existing medications, tirzepatide affects dual pathways – the GLP-1 hormone and the GIP https://tirzepatidepeptide691077.fitnell.com/83135895/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment